Antibiotic Selection for the Geriatric Population – Eric Wombwell – PESI

*** Proof of Product ***

Exploring the Essential Features of “Antibiotic Selection for the Geriatric Population – Eric Wombwell – PESI”

It’s challenging to stay current on the evolving best treatments for c.difficile, community-acquired pneumonia and urinary tract infections. This session will also deliver an evidence-based assessment of penicillin allergies in the geriatric population. Eric Wombwell, PharmD, BCIDP, a board-certified infectious diseases pharmacist, will deliver the very latest updates so you can confidently choose the most effective medications for your older patients, while also considering the importance of minimizing adverse risks.

Speaker

Eric Wombwell, PharmD, BCIDP

Dr. Eric Wombwell is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri – Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.

Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association – UMKC Faculty Member of the Year”, and the “University of Missouri – Kansas City Provost’s Award for Excellence in Teaching”.

Speaker Disclosures:
Financial: Eric Wombwell has an employment relationship with the University of Missouri. He receives a speaking honorarium, recording royalties, and a consulting fee from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Wombwell is a member of the Society of Infectious Diseases Pharmacists, the Missouri Pharmacists Association, American Association of Colleges of Pharmacy, Infectious Diseases Society of America, and Centerpoint Medical Center.

Objectives

1. Evaluate beta-lactam reaction histories to make evidence-based decisions on the need to avoid beta-lactam therapies.
2. Formulate effective care plans that limit risk for Clostridioides difficile infections.
3. Select anti-infectives to treat Clostridioides difficile that reduce the risk for recurrent infections.
4. Develop risk factor–based empiric antibiotic regimens for patients with suspected community-acquired pneumonia.
5. Design safe and effective care plans for urinary tract infections.
6. Choose effective antibiotic therapies that minimize risk for adverse effects in the geriatric population.

Outline

Penicillin Allergy

• Side Effect vs. Allergy
• Reassessing Allergy Statistics
• Cephalosporin Cross-sensitivity

C. difficile Infections

• Vancomycin vs. Fidaxomicin
• Managing Recurrence
• Probiotic Assessment

Community Acquired Pneumonia

• Assess 2019 ATS/IDSA Guidelines
• Streptococcus pneumonia Resistance
• Evaluate and Contrast Oral Therapies for CAP

Urinary Tract Infections

• E.coli Resistance
• Efficacy and safety considerations antibiotics
• Considerations for recurrent UTI

Target Audience

• Nurses
• Nurse Practitioners
• Physician Assistants
• Physicians
• Physical Therapists
• Occupational Therapists
• Speech Language Pathologists
• Nursing Home Administrators

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/